Coryandar (Cory) Gilvary obtained her PhD from Weill Cornell under the direction of Olivier Elemento, where she completed her PhD in record time (~ 3 years). At Weill Cornell her research focused on developing new machine learning techniques for drug development spanning different disease areas like cancer, diabetes and Parksinson’s disease.
Outside of her computational biology research, she spent time developing cutting edge machine learning models at one of the world’s leading quantitative hedge funds.
Currently, Cory leads OneThree’s data science and computational biology efforts and many of her early research projects helped form the core OneThree platform. Most recently she spearheaded OneThree’s internal efforts to provide free toxicity screening to any researchers working on treatment for COVID-19.